Cancer and Diagnostics

Cancer Drug Development

Researchers are invited to submit abstracts for the "Cancer Drug Development" track at the "World Cancer 2024" conference, focusing on advancements in the discovery, development, and clinical translation of novel cancer therapeutics. Abstracts should highlight innovative drug targets, preclinical models, therapeutic modalities, and clinical trial outcomes.

Attendees can expect presentations on cutting-edge approaches to cancer drug discovery and development, including targeted therapy, immunotherapy, combination therapy, and precision medicine strategies. Discussions will cover the latest insights into tumor biology, drug resistance mechanisms, biomarker-driven clinical trials, and emerging therapeutic modalities such as gene therapy and cell-based therapies.

The track will also feature sessions on regulatory considerations, drug repurposing, pharmacokinetics, pharmacodynamics, and innovative trial designs aimed at accelerating the translation of promising therapeutics from bench to bedside. Attendees will have the opportunity to engage with leading experts, share insights, and collaborate on advancing the next generation of cancer therapies.